文献速递消化系统肿瘤胸部肿瘤乳腺癌

风险调整死亡率作为质量代理指标在肿瘤外科优于手术量——基于全国人群数据的医院集中化新视角

Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data.
PubMed 文献 · J Clin Oncol · 2022-01-11

该研究基于德国2010至2018年全国人群数据,纳入五种主要癌症类型的复杂肿瘤手术患者,比较风险标准化死亡率(RSMR)与年手术量作为手术质量代理指标的效果。结果显示,至少50%的高容量医院未被RSMR分组列为低死亡率组;RSMR集中化模型下平均需32例患者转至低死亡率医院以挽救一例生命,而高容量医院需47例;基于RSMR的集中化相比基于手术量可确保所有癌症类型的中位旅行时间更低。作者认为RSMR是衡量手术质量的有前景的代理指标,在有效性、效率和医院可及性方面优于手术量。

要点

  • 至少50%的高容量医院未被RSMR分组列为低死亡率组。
  • RSMR集中化模型下平均需32例患者转院以挽救一例生命,高容量医院需47例。
  • 基于RSMR的集中化相比基于手术量可确保所有癌症类型的中位旅行时间更低。

核心结论

  • RSMR是衡量手术质量的有前景的代理指标,在有效性、效率和医院可及性方面优于手术量。

研究设计与样本

  • 纳入德国2010至2018年间因五种主要癌症类型之一接受复杂肿瘤手术的所有患者,数据分为训练集(2010-2015年)和验证集(2016-2018年)。
  • 在训练集中计算各手术组的年手术量和RSMR五分位数,并将这些阈值应用于验证集。
  • 研究两种系统之间的重叠,模拟低绩效医院的市场退出,并比较基于手术量和基于RSMR排名的有效性和效率。
  • 比较将患者重新分配至特定手术最低死亡率排名最近医院所需的旅行距离或时间。

主要发现

  • 2016至2018年间,158,079例患者在974家医院接受治疗。
  • 至少50%的高容量医院未被RSMR分组列为低死亡率组。
  • 在RSMR集中化模型中,平均需32例接受复杂肿瘤手术的患者转至低死亡率医院以挽救一例生命,而高容量医院需47例。
  • 从最近医院到实施手术医院的旅行时间平均差异从结直肠癌的10分钟到胰腺癌的24分钟不等。
  • 基于RSMR的集中化相比基于手术量的集中化可确保所有癌症类型的中位旅行时间更低,且这些时间低于观察到的水平。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Despite a long-known association between annual hospital volume and outcome, little progress has been made in shifting high-risk surgery to safer hospitals. This study investigates whether the risk-standardized mortality rate (RSMR) could serve as a stronger proxy for surgical quality than volume. METHODS: We included all patients who underwent complex oncologic surgeries in Germany between 2010 and 2018 for any of five major cancer types, splitting the data into training (2010-2015) and validation sets (2016-2018). For each surgical group, we calculated annual volume and RSMR quintiles in the training set and applied these thresholds to the validation set. We studied the overlap between the two systems, modeled a market exit of low-performing hospitals, and compared effectiveness and efficiency of volume- and RSMR-based rankings. We compared travel distance or time that would be required to reallocate patients to the nearest hospital with low-mortality ranking for the specific procedure. RESULTS: Between 2016 and 2018, 158,079 patients were treated in 974 hospitals. At least 50% of high-volume hospitals were not ranked in the low-mortality group according to RSMR grouping. In an RSMR centralization model, an average of 32 patients undergoing complex oncologic surgery would need to relocate to a low-mortality hospital to save one life, whereas 47 would need to relocate to a high-volume hospital. Mean difference in travel times between the nearest hospital to the hospital that performed surgery ranged from 10 minutes for colorectal cancer to 24 minutes for pancreatic cancer. Centralization on the basis of RSMR compared with volume would ensure lower median travel times for all cancer types, and these times would be lower than those observed. CONCLUSION: RSMR is a promising proxy for measuring surgical quality. It outperforms volume in effectiveness, efficiency, and hospital availability for patients.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Baum P, Lenzi J, Diers J, et al. Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data. J Clin Oncol. 2022. PMID: 35015575. doi:10.1200/JCO.21.01488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。